Farmacia e farmacoloxía
Servizo
![Foto de Farmacia e farmacoloxía](/img/noimage.png)
![Foto de Universitat Autònoma de Barcelona](/img/noimage_org.png)
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (26)
2023
-
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Frontiers in Public Health, Vol. 11
2022
-
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 6, pp. 941-953
-
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 236
-
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4909-4925
-
Insights into the Pharmacokinetics and In Vitro Cell‐Based Studies of the Imidazoline I2 Receptor Ligand B06
International Journal of Molecular Sciences, Vol. 23, Núm. 10
-
Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation
Acta Dermato-Venereologica, Vol. 102
2021
-
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 222
-
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362
-
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
European Journal of Medicinal Chemistry, Vol. 225
-
Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas
Biomedicine and Pharmacotherapy, Vol. 140
2020
-
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease
Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633
-
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
Journal of Medicinal Chemistry, Vol. 63, Núm. 17, pp. 9360-9390
-
Impact of changes in the WHO's 2019 update of DDDs on the measurement of adult hospital antibacterial consumption in Catalonia (Spain), 2008-18
JAC-Antimicrobial Resistance, Vol. 2, Núm. 4
-
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease
Neurotherapeutics, Vol. 17, Núm. 4, pp. 1825-1835
-
Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M
Biomedicine and Pharmacotherapy, Vol. 121
2016
-
Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013
Expert Review of Anti-Infective Therapy, Vol. 14, Núm. 1, pp. 137-144
-
Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers
AIDS, Vol. 30, Núm. 16, pp. 2561-2563
2013
-
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern european populations
Carcinogenesis, Vol. 34, Núm. 2, pp. 314-318
-
Pharmacogenomics in colorectal cancer: A genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
Pharmacogenomics Journal, Vol. 13, Núm. 3, pp. 209-217
2010
-
Phe369(7.38) at human 5-HT 7 receptors confers interspecies selectivity to antagonists and partial agonists
British Journal of Pharmacology, Vol. 159, Núm. 5, pp. 1069-1081